These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11179165)

  • 61. [Diagnostic aspects of spontaneous bacterial peritonitis in hepatic cirrhosis with ascites].
    Breda A; Gidoni Guarnieri GL; Moretto F; Freschi P; Pace M; Sanzuol F; Maccioni A
    Minerva Gastroenterol Dietol; 1995 Sep; 41(3):227-30. PubMed ID: 8519861
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ascites and hepatorenal syndrome.
    Gentilini P; Vizzutti F; Gentilini A; La Villa G
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):313-6. PubMed ID: 11338056
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatic encephalopathy.
    Bleibel W; Al-Osaimi AM
    Saudi J Gastroenterol; 2012; 18(5):301-9. PubMed ID: 23006457
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatorenal syndrome.
    Biswas KD; Jain AK
    Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
    Chang CC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Chang T; Huang HC; Lee FY; Lee SD
    Eur J Pharmacol; 2017 May; 802():36-43. PubMed ID: 28238769
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pros and cons of TIPS for refractory ascites.
    Sanyal AJ
    J Hepatol; 2005 Dec; 43(6):924-5. PubMed ID: 16246451
    [No Abstract]   [Full Text] [Related]  

  • 68. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
    Bertino G; Privitera G; Purrello F; Demma S; Crisafulli E; Spadaro L; Koukias N; Tsochatzis EA
    Intern Emerg Med; 2016 Oct; 11(7):905-16. PubMed ID: 27273018
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Management of patients with cirrhosis and ascites].
    Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1999 Mar; 23(3):379-87. PubMed ID: 10384342
    [No Abstract]   [Full Text] [Related]  

  • 71. Management of patients with complications of cirrhosis.
    Fowler C
    Nurse Pract; 2013 Apr; 38(4):14-21; quiz 22-3. PubMed ID: 23454902
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [German S 3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome"].
    Gerbes AL; Gülberg V; Sauerbruch T; Wiest R; Appenrodt B; Bahr MJ; Dollinger MM; Rössle M; Schepke M
    Z Gastroenterol; 2011 Jun; 49(6):749-79. PubMed ID: 21638242
    [No Abstract]   [Full Text] [Related]  

  • 73. [Ascites in pregnancy in liver cirrhosis].
    Huchzermeyer H
    Z Geburtshilfe Gynakol; 1970 Apr; 172(2):142-8. PubMed ID: 5516067
    [No Abstract]   [Full Text] [Related]  

  • 74. [Spontaneous bacterial peritonitis in the patients with liver cirrhosis].
    Jarcuska P; Veselíny E; Orolín M; Takácová V; Hancová M
    Klin Mikrobiol Infekc Lek; 2004 Dec; 10(6):265-70. PubMed ID: 15672324
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Hepatorenal syndrome].
    Pillebout E
    Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Method report: German S3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome"].
    Gerbes AL; Sauerbruch T; Dathe K
    Z Gastroenterol; 2011 Jun; 49(6):780-7. PubMed ID: 21638243
    [No Abstract]   [Full Text] [Related]  

  • 77. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.
    Madsen BS; Havelund T; Krag A
    Adv Ther; 2013 Jul; 30(7):659-70. PubMed ID: 23881723
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical course and short-term mortality of cirrhotic patients with infections other than spontaneous bacterial peritonitis.
    Fernández J; Acevedo J; Prado V; Mercado M; Castro M; Pavesi M; Arteaga M; Sastre L; Juanola A; Ginès P; Arroyo V
    Liver Int; 2017 Mar; 37(3):385-395. PubMed ID: 27558198
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
    Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
    World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.